Susan M. Molineaux
Independent DirectorDr. Susan M. Molineaux, Ph.D., is Chief Executive Officer of Synthekine, Inc. from August 2026 and is Director since August 2026 She served as Business Advisor of Juvena Therapeutics, Inc. since July 2025 until September 2026. She serves as an Independent Director at Repare Therapeutics Inc. since June 08, 2023. She served as President and Chief Executive Officer of Para Therapeutics Inc., a position she has held from April 2023 to July 2025. She served as an Independent Director at Cyteir Therapeutics, Inc. since 2020 until 2023. She Founded Calithera Biosciences, Inc. in March 2010 and had been its Chief Executive Officer, President and Director since March 2010 until March 2023. Dr. Molineaux also serves as Principal Financial Officer of Calithera Biosciences, Inc. Dr. Molineaux Co-founded Proteolix, Inc. (now known as Onyx Therapeutics, Inc.) in December 2003, where she served as Chief Scientific Officer from December 2003 to December 2005, Chief Executive Officer from January 2006 to January 2009 and again as Chief Scientific Officer from February 2009 until Proteolix's acquisition by Onyx Pharmaceuticals, Inc. in November 2009. She served as President of Proteolix, Inc. Prior to joining Proteolix, Inc., Dr. Molineaux was at Rigel Pharmaceuticals Inc. in South San Francisco, CA from 2000 to 2003, where she served as Vice President of Biology and Senior Director. Prior to that, she served as Vice President of Biology at Praelux in Lawrenceville, NJ from 1999 to 2000. From 1994 to 1999, Dr. Molineaux served as Vice President of Drug Development at Praecis Pharmaceuticals, Inc. in Cambridge, MA and from 1989 to 1994, she was a Scientist in the Immunology group at Merck & Company, in Rahway, NJ. She serves as Director of BayBio. She has been an Independent Director of Geron Corporation since September 26, 2012. She was Independent Director at Theravance Biopharma, Inc. since April 22, 2015 until April 26, 2022. She is Advisor to LSV Capital Management, LLC. Earlier she was Scientific Advisor at the firm since September 2016. She served as Director of Proteolix Inc. She serves as a Member of the Board of Directors of We Teach Science and served as California Life Sciences Association until March 2016. Dr. Molineaux serves as a Member of the Board of Directors of Smith College. She served as Director of Bay Area Bioscience Association. Dr. Molineaux received a BS in Biology from Smith College, a Ph.D. in Molecular Biology from Johns Hopkins University and completed a postdoctoral fellowship at Columbia University.
Positions
- Company NameGeron CorporationStock CodeGERNPositionIndependent DirectorColleagues
- HSHarout SemerjianCEO, President & Director
- EGElizabeth G. O'FarrellIndependent Chairman of the Board
- MJMichelle J. RobertsonEVP, CFO, Treasurer and Principal Financial & Accounting Officer
- JEJoseph Emile EidExecutive VP of Research & Development and Chief Medical Officer
- AEAhmed ElNawawiExecutive VP & Chief Commercial Officer
- STShanthakumar TyavanagimattSenior VP & Chief Technical Officer
- DCDawn Carter BirIndependent Director
- RJRobert Jay SpiegelIndependent Director
